WHO ICTRP trial
This is a study in blood cancer patients. We will try a new approach to make the…
CTRI/2020/10/028549 · Clinical Trials Registry India (CTRI) · Recruiting
Key facts
| Trial ID | CTRI/2020/10/028549 |
|---|---|
| Public title | This is a study in blood cancer patients. We will try a new approach to make the patients treatment free.This research will try to find out how much a medicine called Pomalidomide is helpful in this method. |
| Scientific title | A phase II study to evaluate the role of short-course Pomalidomide in maintaining treatment-free remission post tyrosine-kinase inhibitor (TKI) discontinuation in adult patients with chronic myeloid leukemia-chronic phase (CML-CP). - REFLECT CML |
| Primary sponsor | TRAC TMC Research Administrative Council |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Recruiting |
| Study type | Interventional |
| Phase | Phase 2 |
| Countries | India |
| Conditions | Health Condition 1: C921- Chronic myeloid leukemia, BCR/ABL-positive |
| Interventions | Intervention1: Pomalidomide: Pomalidomide for a period of 6 months will increase the 12-month molecular relapse free survival (mRFS) by 10 %( hence prevent haematological relapse). Pomalidomide has a longer half-life which will reduce… |
| Registration date | Oct 22, 2020 |
| Target size | 110 |
| Secondary IDs | NIL |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: